The Social Engineering Attack Spiral (SEAS)

YesCybercrime is on the increase and attacks are becoming ever more sophisticated. Organisations are investing huge sums of money and vast resources in trying to establish effective and timely countermeasures. This is still a game of catch up, where hackers have the upper hand and potential victims are trying to produce secure systems hardened against what feels like are inevitable future attacks. The focus so far has been on technology and not people and the amount of resource allocated to countermeasures and research into cyber security attacks follows the same trend. This paper adds to the growing body of work looking at social engineering attacks and therefore seeks to redress this imbalance to some extent. The objective is to produce a model for social engineering that provides a better understanding of the attack process such that improved and timely countermeasures can be applied and early interventions implemented

A preliminary radicalisation framework based on social engineering techniques

YesThe use of online forums and social media sites by extremists for recruiting and radicalising individuals has been covered extensively by researchers. Meanwhile, the social engineering techniques utilised by these extremists to lure marginalised individuals into radicalisation has been neglected. In this article, the social engineering aspects of online radicalisation will be explored. Specifically, the five Principles of Persuasion in Social Engineering (PPSE) will be mapped onto the online radicalisation methods employed by extremists online. Analysing these tactics will aid in gaining a deeper understanding of the process of indoctrination and of the psychology of both the attacker and the target of such attacks. This understanding has enabled the development of a preliminary radicalisation framework based on the social traits of a target that may be exploited during an attack

Cyber Threat Intelligence from Honeypot Data using Elasticsearch

yesCyber attacks are increasing in every aspect of daily life. There are a number of different technologies around to tackle cyber-attacks, such as Intrusion Detection Systems (IDS), Intrusion Prevention Systems (IPS), firewalls, switches, routers etc., which are active round the clock. These systems generate alerts and prevent cyber attacks. This is not a straightforward solution however, as IDSs generate a huge volume of alerts that may or may not be accurate: potentially resulting in a large number of false positives. In most cases therefore, these alerts are too many in number to handle. In addition, it is impossible to prevent cyber-attacks simply by using tools. Instead, it requires greater intelligence in order to fully understand an adversary’s motive by analysing various types of Indicator of Compromise (IoC). Also, it is important for the IT employees to have enough knowledge to identify true positive attacks and act according to the incident response process. In this paper, we have proposed a new threat intelligence technique which is evaluated by analysing honeypot log data to identify behaviour of attackers to find attack patterns. To achieve this goal, we have deployed a honeypot on an AWS cloud to collect cyber incident log data. The log data is analysed by using elasticsearch technology namely an ELK (Elasticsearch, Logstash and Kibana) stack

Physical activity attitudes, intentions and behaviour among 18-25 year olds: a mixed method study

Peer reviewedPublisher PD

Slow recovery of High Arctic heath communities from nitrogen enrichment

Acknowledgements We are indebted to Ian Alexander who initiated the fertilisation experiment with SJW; to successive researchers involved in the experiment, John Baddeley, Nanette Madan, Lars Hogbom, Bernard Moyersen, Carmen Gordon; and to field assistants, Alison Horsburgh, Andrew Coughlan, Jo Wynn, Lora Crabtree. We thank Hans Kruijer and Michael Stech for assistance with bryophyte species identification in 2011. Funding for the initial experiment was provided by the NERC Arctic Terrestrial Ecology Special Topic Programme (GR3/9424, GR9/3433) with additional support from the CEC TMR Programme, Ny-Ålesund LSF and the British Ecological Society. This recovery study was funded by NERC (NE/I016899/1). The research was made possible by use of NERC facilities at Harland Huset; special thanks to Nick Cox and colleagues for their unfailing hospitality and support.Peer reviewedPostprintPostprin

Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors

Background: Limits on the frequency of whole blood donation exist primarily to safeguard donor health. However, there is substantial variation across blood services in the maximum frequency of donations allowed. We compared standard practice in the UK with shorter inter-donation intervals used in other countries. Methods: In this parallel group, pragmatic, randomised trial, we recruited whole blood donors aged 18 years or older from 25 centres across England, UK. By use of a computer-based algorithm, men were randomly assigned (1:1:1) to 12-week (standard) versus 10-week versus 8-week inter-donation intervals, and women were randomly assigned (1:1:1) to 16-week (standard) versus 14-week versus 12-week intervals. Participants were not masked to their allocated intervention group. The primary outcome was the number of donations over 2 years. Secondary outcomes related to safety were quality of life, symptoms potentially related to donation, physical activity, cognitive function, haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin. This trial is registered with ISRCTN, number ISRCTN24760606, and is ongoing but no longer recruiting participants. Findings: 45 263 whole blood donors (22 466 men, 22 797 women) were recruited between June 11, 2012, and June 15, 2014. Data were analysed for 45 042 (99·5%) participants. Men were randomly assigned to the 12-week (n=7452) versus 10-week (n=7449) versus 8-week (n=7456) groups; and women to the 16-week (n=7550) versus 14-week (n=7567) versus 12-week (n=7568) groups. In men, compared with the 12-week group, the mean amount of blood collected per donor over 2 years increased by 1·69 units (95% CI 1·59–1·80; approximately 795 mL) in the 8-week group and by 0·79 units (0·69–0·88; approximately 370 mL) in the 10-week group (p<0·0001 for both). In women, compared with the 16-week group, it increased by 0·84 units (95% CI 0·76–0·91; approximately 395 mL) in the 12-week group and by 0·46 units (0·39–0·53; approximately 215 mL) in the 14-week group (p<0·0001 for both). No significant differences were observed in quality of life, physical activity, or cognitive function across randomised groups. However, more frequent donation resulted in more donation-related symptoms (eg, tiredness, breathlessness, feeling faint, dizziness, and restless legs, especially among men [for all listed symptoms]), lower mean haemoglobin and ferritin concentrations, and more deferrals for low haemoglobin (p<0·0001 for each) than those observed in the standard frequency groups. Interpretation: Over 2 years, more frequent donation than is standard practice in the UK collected substantially more blood without having a major effect on donors' quality of life, physical activity, or cognitive function, but resulted in more donation-related symptoms, deferrals, and iron deficiency. Funding: NHS Blood and Transplant, National Institute for Health Research, UK Medical Research Council, and British Heart Foundation

Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors

Background: The INTERVAL trial showed that, over a 2-year period, inter-donation intervals for whole blood donation can be safely reduced to meet blood shortages. We extended the INTERVAL trial for a further 2 years to evaluate the longer-term risks and benefits of varying inter-donation intervals, and to compare routine versus more intensive reminders to help donors keep appointments. Methods: The INTERVAL trial was a parallel group, pragmatic, randomised trial that recruited blood donors aged 18 years or older from 25 static donor centres of NHS Blood and Transplant across England, UK. Here we report on the prespecified analyses after 4 years of follow-up. Participants were whole blood donors who agreed to continue trial participation on their originally allocated inter-donation intervals (men: 12, 10, and 8 weeks; women: 16, 14, and 12 weeks). They were further block-randomised (1:1) to routine versus more intensive reminders using computer-generated random sequences. The prespecified primary outcome was units of blood collected per year analysed in the intention-to-treat population. Secondary outcomes related to safety were quality of life, self-reported symptoms potentially related to donation, haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin and other factors. This trial is registered with ISRCTN, number ISRCTN24760606, and has completed. Findings: Between Oct 19, 2014, and May 3, 2016, 20 757 of the 38 035 invited blood donors (10 843 [58%] men, 9914 [51%] women) participated in the extension study. 10 378 (50%) were randomly assigned to routine reminders and 10 379 (50%) were randomly assigned to more intensive reminders. Median follow-up was 1·1 years (IQR 0·7–1·3). Compared with routine reminders, more intensive reminders increased blood collection by a mean of 0·11 units per year (95% CI 0·04–0·17; p=0·0003) in men and 0·06 units per year (0·01–0·11; p=0·0094) in women. During the extension study, each week shorter inter-donation interval increased blood collection by a mean of 0·23 units per year (0·21–0·25) in men and 0·14 units per year (0·12–0·15) in women (both p<0·0001). More frequent donation resulted in more deferrals for low haemoglobin (odds ratio per week shorter inter-donation interval 1·19 [95% CI 1·15–1·22] in men and 1·10 [1·06–1·14] in women), and lower mean haemoglobin (difference per week shorter inter-donation interval −0·84 g/L [95% CI −0·99 to −0·70] in men and −0·45 g/L [–0·59 to −0·31] in women) and ferritin concentrations (percentage difference per week shorter inter-donation interval −6·5% [95% CI −7·6 to −5·5] in men and −5·3% [–6·5 to −4·2] in women; all p<0·0001). No differences were observed in quality of life, serious adverse events, or self-reported symptoms (p>0.0001 for tests of linear trend by inter-donation intervals) other than a higher reported frequency of doctor-diagnosed low iron concentrations and prescription of iron supplements in men (p<0·0001). Interpretation: During a period of up to 4 years, shorter inter-donation intervals and more intensive reminders resulted in more blood being collected without a detectable effect on donors' mental and physical wellbeing. However, donors had decreased haemoglobin concentrations and more self-reported symptoms compared with the initial 2 years of the trial. Our findings suggest that blood collection services could safely use shorter donation intervals and more intensive reminders to meet shortages, for donors who maintain adequate haemoglobin concentrations and iron stores. Funding: NHS Blood and Transplant, UK National Institute for Health Research, UK Medical Research Council, and British Heart Foundation

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

SummaryBackground Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatoryactions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospitalwith COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients wererandomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once perday by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatmentgroups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment andwere twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants andlocal study staff were not masked to the allocated treatment, but all others involved in the trial were masked to theoutcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treatpopulation. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) wereeligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomlyallocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall,561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days(rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days(rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, nosignificant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilationor death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24).Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or otherprespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restrictedto patients in whom there is a clear antimicrobial indication

The role of clinical and social cognitive variables in parasuicide

Objectives: The central aim of the present study was to investigate the extent to which social cognitive variables could mediate the effects of past self-harm behaviour and clinical variables on intentions to engage in deliberate self-harm (DSH) and suicidality in the next three months. In addition, we aimed to extend the application of the theory of planned behaviour (TPB) beyond distal health outcomes to a behaviour that is proximal and extreme. Design and method: A prospective study design was employed. Ninety parasuicide patients admitted via accident and emergency to a general hospital completed measures of hopelessness, depression, anxiety, past self-harm behaviour, standard TPB and group identity measures within days of an overdose. Three months later, participants were asked to complete a measure of suicidal thinking and behaviour. Results: There was clear evidence that the social cognitive variables were significant predictors of intention to engage in DSH and suicidality three months later. Depression was the only clinical variable which remained significant when all variables were entered into the final model to predict intentions. Attitudes, self-efficacy and intention mediated the clinical variables-suicidality relationship. Conclusions: The TPB is a useful framework for understanding suicidal behaviour. The results extend the application of the TPB beyond distal health outcomes to a behaviour that is both proximal and extreme. Future research should explore the implications for screening assessment and suicide prevention